Showing results (491-500 of 726) with videos related to
Sort By:
Pageof 73
The Journal of Experimental Medicine|July 29, 2009
The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1)Svenja Steinfelder, John F Andersen, Jennifer L Cannons, et al.Bone Marrow Transplantation|June 30, 1998
High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cellsC H Weaver, T Moss, L S Schwartzberg, et al.Bone Marrow Transplantation|December 24, 1997
A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinomaC H Weaver, F A Greco, J D Hainsworth, et al.Leukemia|February 20, 2003
Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195E Feldman, M Kalaycio, G Weiner, et al.Science (New York, N.Y.)|November 26, 2002
A critical role for IL-21 in regulating immunoglobulin productionKatsutoshi Ozaki, Rosanne Spolski, Carl G Feng, et al.Cancer Biotherapy & Radiopharmaceuticals|June 18, 2015
Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of TreatmentRobert O Dillman, Edward F McClay, Neil M Barth, et al.Immunity|July 25, 2006
Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and RlkChristine Broussard, Christine Fleischacker, Christine Fleischecker, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanomaR O Dillman, S K Nayak, N M Barth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III studyCharles L Vogel, Marek Z Wojtukiewicz, Robert R Carroll, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC)Anshu K Jain, Randall S Hughes, Alan B Sandler, et al.Pageof 73